A global pharmaceutical company worked with us to plan their European Union (EU) access strategy for a novel oncolytic drug based on a new formulation. Read the case study.
Menu
Our integrated team of experts collaborates seamlessly to gather insights, craft market access strategies, develop tactical plans, and oversee flawless implementation. We foster cross-functional teams to align price with product value, ensure maximum access for patients and reimbursement. With commercial experience that spans across 25+ therapeutic areas and a client base boasting an average tenure of 7 years, our success is a testament to our agile organizational structure and proven frameworks. By overcoming the barriers to patient access, we enable you to realize your brand goals and improve the patient experience.
Our experienced team, a powerhouse of seasoned market access leaders responsible for driving success in some of the industry’s most prominent pharmaceutical brands, has a diverse array of talent, including MBAs, MDs, PharmDs, and epidemiologists.
Jay Jackson, PharmD, MPH, BCMAS is a partner at Herspiegel and an experienced market access professional within the biopharmaceutical, medical device, and digital therapeutics industry. For more than 20 years, Jay has partnered with US and global clients of varying sizes and product portfolios to provide value-driven solutions that demonstrate brand value and maximize patient access to therapies. He has experience across multiple therapeutic areas, including oncology, cardiovascular, respiratory, autoimmune, infectious disease, central nervous system disorders, and rare diseases. He received his Doctor of Pharmacy degree from the Mercer University Southern School of Pharmacy and a Master of Public Health in Epidemiology from the University of South Florida College of Public Health. He also has postdoctoral training that includes the completion of an Outcomes Research Fellowship and a Board Certification in Medical Affairs.
Principal, Value and Access Communications
Principal, Market Access
Principal, Evidence and Value
Principal, Market Access
Principal, Market Access
Add more content
